Tsuchiya, Takashi <br/><br/>
Safety analysis of two different regimens of uracil-tegafur plus leucovorin as adjuvant chemotherapy for high-risk stage II and III colon cancer in a phase III trial comparing 6 with 18 months of treatment: JFMC33-0502 trial.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  Jun 2014 
 - 1253-61 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0843 
<br/><br/><label>Standard No.: </label>10.1007/s00280-014-2461-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Chemotherapy, Adjuvant<br/>Colonic Neoplasms--drug therapy<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Leucovorin--administration & dosage<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Risk Factors<br/>Tegafur--administration & dosage<br/>Uracil--administration & dosage